AI assistant
Sending…
Oramed Pharmaceuticals Inc. — Director's Dealing 2021
Oct 15, 2021
6965_dirs_2021-10-15_96fe3d03-31f0-4b9d-8463-4ddc8bbb3d99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2021-08-31
Reporting Person: Friedman Aviad (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-04 | Common Stock | G | 12191 | — | Disposed | 0 | Indirect |
| 2021-07-04 | Common Stock | G | 10000 | — | Disposed | 0 | Direct |
Footnotes
F1: These shares of common stock were transferred, for no consideration, to a trust with an independent trustee.
More from Oramed Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Capital/Financing Update
2026
Feb 20
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29
Director's Dealing
2026
Jan 29